Which has the lower trailing P/E, KNSA or MMSI?

MMSI has the lower trailing P/E: KNSA trades at 76.78 and MMSI at 35.17. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, KNSA or MMSI?

Over the past five years, KNSA grew revenue faster — KNSA at a 155.66% CAGR versus MMSI at 8.90%.

Is KNSA or MMSI more profitable?

KNSA runs the higher net margin — KNSA at 9.59% versus MMSI at 9.22%.

How have KNSA and MMSI total returns compared?

Over the past 5 years, KNSA delivered 47.48% and MMSI delivered 3.88% annualized total return. Past performance doesn't predict future results.

Kiniksa Pharmaceuticals International, plc (KNSA) vs Merit Medical Systems, Inc. (MMSI)

A side-by-side comparison of Kiniksa Pharmaceuticals International, plc and Merit Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

KNSA

Kiniksa Pharmaceuticals International, plc

$5.73B

$75.24HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT

MMSI

Merit Medical Systems, Inc.

$5.08B

$85.12HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT

Total return — KNSA vs MMSI

growth of $100 · dividends reinvested · last 8y

KNSA +291.9% (+18.6%/yr)MMSI +60.0% (+6.1%/yr)KNSA compounded faster over this window

KNSA MMSI

KNSA vs MMSI: by the numbers

•KNSA is the larger company ($5.73B vs $5.08B market cap).
•MMSI trades at the lower trailing earnings multiple (35.17 vs 76.78 P/E), one valuation lens rather than an overall verdict.
•KNSA converts more revenue to profit (9.59% vs 9.22% net margin).
•KNSA grew revenue faster over the past five years (155.66% vs 8.90% CAGR).

Metrics side by side

Valuation

Metric	KNSA	MMSI
P/E ratio	76.78	35.17
Forward P/E	54.02	19.78
P/S ratio	6.82	3.22
P/B ratio	8.77	3.03
EV / EBITDA	54.56	16.17
FCF yield	3.19%	4.00%

Profitability

Metric	KNSA	MMSI
Gross margin	54.49%	49.52%
Operating margin	11.92%	12.75%
Net margin	9.59%	9.22%
ROE	12.33%	8.67%
ROIC	9.76%	5.80%

Growth (annualized)

Metric	KNSA	MMSI
Revenue CAGR (5Y)	155.66%	8.90%
FCF CAGR (5Y)	N/A	8.96%
Total return CAGR (5Y)	47.48%	3.88%

Frequently asked

Which has the lower trailing P/E, KNSA or MMSI?: MMSI has the lower trailing P/E: KNSA trades at 76.78 and MMSI at 35.17. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, KNSA or MMSI?: Over the past five years, KNSA grew revenue faster — KNSA at a 155.66% CAGR versus MMSI at 8.90%.
Is KNSA or MMSI more profitable?: KNSA runs the higher net margin — KNSA at 9.59% versus MMSI at 9.22%.
How have KNSA and MMSI total returns compared?: Over the past 5 years, KNSA delivered 47.48% and MMSI delivered 3.88% annualized total return. Past performance doesn't predict future results.

Go deeper

Full KNSA analysis Full MMSI analysis Interactive comparison tool

Dig into the metrics

Kiniksa Pharmaceuticals International P/E ratio Merit Medical Systems P/E ratio Kiniksa Pharmaceuticals International ROE Merit Medical Systems ROE Kiniksa Pharmaceuticals International operating margin Merit Medical Systems operating margin Kiniksa Pharmaceuticals International revenue growth Merit Medical Systems revenue growth Kiniksa Pharmaceuticals International free cash flow Merit Medical Systems free cash flow

Kiniksa Pharmaceuticals International & Merit Medical Systems appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.